Armitage, Ian G.,Chopra, Reenu,Cooper, Martin Ian,Langston, Marianne
申请号:
AU2013204831
公开号:
AU2013204831A1
申请日:
2013.04.12
申请国别(地区):
AU
年份:
2013
代理人:
摘要:
#$%^&*AU2013204831A120130509.pdf#####H:\SXD\Intenvoven\NRPorlbl\DCC\SXD\5072063_I.doc-12/04/2013 ABSTRACT Disclosed is a compound of formula (1) crystalline forms thereof, and solvates thereof pharmaceutical compositions comprising a pharmaceutically effective amount of the compound of formula (I), or a crystalline form thereof, or a solvate thereof, and a pharmaceutically acceptable carrier or diluent and the use of a compound of formula (1), or a crystalline form thereof, or a solvate thereof, for treating a patient suffering from, or subject to, a pathological condition capable of being ameliorated by inhibiting an El activating enzyme, particularly NAE, including, e.g., cancer. NH N aN .. N .HCI H2N HO